PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses change of 100.00% versus flat Healthcare costs. Walter Schloss would verify efficiency.
752.87%
Operating expenses growth exceeding 1.5x Healthcare median of 1.92%. Jim Chanos would check for waste.
752.87%
Total costs growth exceeding 1.5x Healthcare median of 2.18%. Jim Chanos would check for waste.
22.99%
Interest expense change of 22.99% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
-552.87%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-552.87%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
675.86%
Tax expense change of 675.86% versus flat Healthcare. Walter Schloss would verify strategy.
-675.86%
Net income decline while Healthcare median is 0.08%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-2175.00%
EPS decline while Healthcare median is 4.30%. Seth Klarman would investigate causes.
-2175.00%
Diluted EPS decline while Healthcare median is 5.24%. Seth Klarman would investigate causes.
-66.67%
Share count reduction while Healthcare median is 0.11%. Seth Klarman would investigate strategy.
-66.67%
Diluted share reduction while Healthcare median is 0.06%. Seth Klarman would investigate strategy.